Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$1.04B |
| 2 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$753M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$717M |
| 4 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$653M |
| 5 |
Microsoft
MSFT
|
+$421M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TotalEnergies
TTE
|
+$427M |
| 2 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$380M |
| 3 |
STJ
St Jude Medical
STJ
|
+$235M |
| 4 |
JPMorgan Chase
JPM
|
+$211M |
| 5 |
LLTC
Linear Technology Corp
LLTC
|
+$175M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.74% |
| 2 | Healthcare | 5.25% |
| 3 | Financials | 4.26% |
| 4 | Communication Services | 3.9% |
| 5 | Consumer Discretionary | 3.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CRR
4076
CALL
DELISTED
Carbo Ceramics Inc.
CRR
| $235K | ﹤0.01% |
18,000
-6,200
| -26% | -$79.3K |
|
4077
Intrepid Potash
IPI
$453M
| $234K | ﹤0.01% |
13,575
+12,441
| +1,097% | +$241K |
|
4078
PUT
Smith & Wesson
SWBI
$658M
| $234K | ﹤0.01% |
15,352
-2,472
| -14% | -$37.7K |
|
|
NVRO
4079
CALL
DELISTED
NEVRO CORP.
NVRO
| $234K | ﹤0.01% |
+2,500
| New | +$226K |
|
|
NAV
4080
PUT
DELISTED
Navistar International
NAV
| $234K | ﹤0.01% |
9,500
-221,200
| -96% | -$6.08M |
|
|
DO
4081
PUT
DELISTED
Diamond Offshore Drilling
DO
| $234K | ﹤0.01% |
14,000
-80,200
| -85% | -$1.36M |
|
4082
Atlanta Braves Holdings Series B
BATRK
$3.19B
| $233K | ﹤0.01% |
9,875
-2,350
| -19% | -$50.2K |
|
|
TOWR
4083
DELISTED
Tower International, Inc.
TOWR
| $233K | ﹤0.01% |
8,586
+5,214
| +155% | +$141K |
|
|
ARII
4084
DELISTED
American Railcar Industries, Inc.
ARII
| $233K | ﹤0.01% |
5,654
+4,572
| +423% | +$201K |
|
4085
CALL
iShares 7-10 Year Treasury Bond ETF
IEF
$47.3B
| $232K | ﹤0.01% |
2,200
-16,600
| -88% | -$1.74M |
|
4086
CALL
Jazz Pharmaceuticals
JAZZ
$16.4B
| $232K | ﹤0.01% |
1,600
| – | – |
|
4087
CALL
Teekay
TK
$946M
| $232K | ﹤0.01% |
25,400
+9,000
| +55% | +$87.1K |
|
4088
Texas Roadhouse
TXRH
$13.7B
| $232K | ﹤0.01% |
5,224
-17,571
| -77% | -$791K |
|
4089
Federal Signal
FSS
$7.95B
| $231K | ﹤0.01% |
16,650
+9,403
| +130% | +$142K |
|
4090
LeMaitre Vascular
LMAT
$1.81B
| $231K | ﹤0.01% |
+9,346
| New | +$219K |
|
4091
Century Communities
CCS
$2.03B
| $230K | ﹤0.01% |
9,085
+8,878
| +4,289% | +$205K |
|
4092
CALL
Zillow
ZG
$8.44B
| $230K | ﹤0.01% |
6,800
-77,900
| -92% | -$2.78M |
|
4093
iShares MSCI Indonesia ETF
EIDO
$493M
| $229K | ﹤0.01% |
+8,865
| New | +$220K |
|
4094
CALL
Jefferies Financial Group
JEF
$13B
| $229K | ﹤0.01% |
9,831
-16,198
| -62% | -$362K |
|
4095
Ooma
OOMA
$590M
| $229K | ﹤0.01% |
+23,042
| New | +$222K |
|
|
RDUS
4096
PUT
DELISTED
Radius Recycling
RDUS
| $229K | ﹤0.01% |
11,100
+6,600
| +147% | +$154K |
|
|
SGMO
4097
CALL
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $229K | ﹤0.01% |
44,100
-20,100
| -31% | -$80.6K |
|
4098
Trustmark
TRMK
$2.83B
| $229K | ﹤0.01% |
7,182
-4,300
| -37% | -$143K |
|
|
ADXS
4099
DELISTED
Advaxis Inc
ADXS
| $229K | ﹤0.01% |
1,871
+202
| +12% | +$26.2K |
|
|
CHA
4100
DELISTED
China Telecom Corporation, LTD
CHA
| $229K | ﹤0.01% |
4,704
| – | – |
|
Similar funds
Barclays's Q1 2017 Portfolio in Review
As of Q1 2017, Barclays held 7,315 positions worth $91.9B, down 0.67% from $92.5B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Barclays withdrew a net $6.3B in Q1 2017, closing 393 positions and reducing 3,105 holdings. Its most notable exit was St Jude Medical, an estimated $235M position sold in full.
By sector, the portfolio is most concentrated in Technology at 5.7% of assets, up from 4.7% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Barclays opened a new position in iPath S&P VEQTOR ETN worth $95.8M.
- Barclays's largest Q1 2017 buy was iPath S&P VEQTOR ETN: 670,000 shares worth $95.8M.
- Barclays added most to State Street Consumer Discretionary Select Sector SPDR ETF in Q1 2017, an estimated $1.04B increase.
- Barclays's biggest Q1 2017 reduction was TotalEnergies, cutting an estimated $427M.
- Barclays fully exited St Jude Medical in Q1 2017, selling an estimated $235M.
- Barclays's ten largest holdings make up 34% of its $91.9B portfolio in Q1 2017.
- Barclays opened 572 new positions and closed 393 in Q1 2017.
- Barclays's portfolio value fell 0.67% quarter-over-quarter to $91.9B.
Based on Barclays's 13F filing for Q1 2017, filed 15 May 2017.